Category: Covid-19

The objective of this External Quality Assessment (EQA) is to strengthen the capacity for genomic epidemiology and public health bioinformatics.

In the EU/EEA countries, activity of influenza viruses, respiratory syncytial viruses and SARS-CoV-2 continue to remain at relatively low levels.

Activity of influenza viruses, respiratory syncytial viruses and SARS-CoV-2 remained at relatively low levels in week 44 in the EU/EEA countries.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 November 2024 and includes updates on avian influenza, Middle East respiratory virus syndrome, West Nile virus, dengue, mpox, Marburg virus disease, and an overview or respiratory virus epidemiology in the EU/EEA.

Activity of influenza viruses, respiratory syncytial viruses and SARS-CoV-2 remained at relatively low levels in week 43 in the EU/EEA countries.

The EU/EEA Respiratory Virus Network meeting was organised by the European Centre for Disease Prevention and Control between 12 – 14 June 2024 in Stockholm, Sweden.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 26 October – 1 November 2024 and includes updates on the severe flooding in Eastern Spain, SARS-CoV-2 variants, avian influenza A(H5N1), West Nile Virus infection, dengue, mpox, Marburg virus disease (MVD), and Oropouche virus disease.

Seasonal influenza and COVID-19 vaccination uptake for risk groups such as the elderly were sub-optimal in several EU/EEA Member States during the 2023-2024 season, according to two reports released today by the European Centre for Disease Prevention and Control (ECDC).

This report presents a description of COVID-19 vaccine coverage in the European Union/European Economic Area (EU/EEA) between 1 September 2023 and 31 July 2024.

Post Content